Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Never take two doses to catch up
Across the SURPASS clinical trials, researchers categorized injection site reactions into several distinct presentations
Whether the need is for a diagnostic workup, a second opinion, or active treatment, the process is designed to be coordinated rather than fragmented
Once approved, its expected to redefine the standard of care for obesity management
Eli Lilly, the pharmaceutical company developing retatrutide, has progressed the compound into Phase 3 clinical trials, which are evaluating its efficacy and safety in larger populations across multiple indications, including obesity and type 2 diabetes
US$ 20.79
US$ 27.31
US$ 22.11
US$ 26.18
US$ 21.46
US$ 29.35
